Amphastar Pharmaceuticals (AMPH) Q3 Earnings and Revenues Beat Estimates

Published on November 8, 2021

Amphastar (AMPH) delivered earnings and revenue surprises of 109.09% and 8.93%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?